The strong correlation between decreased E-cadherin levels and increased MMP9 expression and clinicopathological parameters that has been observed in many human tumors, including ovarian, gastric, and esophageal cancers, may confirm that this complex interplay is of crucial importance for cancer development and progression [74,76,77]. Here, MMP9 is linked to cancer.